AMENDMENT TO THE MASTER DEVELOPMENT AND LICENSE AGREEMENT FOR {***} BETWEEN ELITE PHARMACEUTICALS, INC. AND MIKAH PHARMA, LLCMaster Development and License Agreement • November 14th, 2011 • Elite Pharmaceuticals Inc /De/ • Pharmaceutical preparations
This Amendment, dated as of November 1, 2011 (the “Amendment”), by and between Elite Pharmaceuticals, Inc. and Elite Laboratories, Inc. (a subsidiary of Elite Pharmaceuticals, Inc.), both corporations organized under the laws of the State of Delaware, with offices at 165 Ludlow Avenue, Northvale, New Jersey (“Elite”), and Mikah Pharma, LLC, a Delaware limited liability company with its offices at 20 Kilmer Drive, Hillsborough, New Jersey 08844 (“Mikah”) relating to that Master Development and License Agreement For {***} (the “Agreement”), dated August 27, 2010, by and between Elite and Mikah;
